HALO•prnewswire•
Halozyme Wins Preliminary Injunction Against Merck's Keytruda SC in Germany
Summary
SAN DIEGO, Dec. 4, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme), announced today that a German court has granted its request for a preliminary injunction ordering Merck to refrain from distributing and offering Keytruda SC in Germany. The Munich Regional...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 4, 2025 by prnewswire